Name: AROATXN2-1001: A Phase 1 Placebo-controlled Study to Evaluate ARO-ATXN2 in Adult Subjects with Spinocerebellar Ataxia Type 2
Start: 2025-09-08T10:00:00-05:00
End: 2025-09-08T11:00:00-05:00
Location: Zoom Webinar

<< All Events

AROATXN2-1001: A Phase 1 Placebo-controlled Study to Evaluate ARO-ATXN2 in Adult Subjects with Spinocerebellar Ataxia Type 2

September 8, 2025 @ 10:00 am - 11:00 am

CENTRAL TIME ZONE

This webinar will provide information about Arrowhead Pharmaceuticals’ ongoing Phase 1 study of ARO-ATXN2 in patients with Spinocerebellar Ataxia Type 2 (SCA2), including the rationale for an siRNA therapeutic approach, an overview of the study design and eligibility requirements for participation, and how patients can contact sites to learn more.

Other Webinars

NAF hosts educational webinars about Ataxia presented by industry experts. Learn about important topics related to living with Ataxia. Webinars are complimentary for NAF members, with new sessions offered each month. Join NAF to receive invitations to upcoming Ataxia webinars. Visit www.ataxia.org/webinars to explore past webinars on a variety of topics.